Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett's esophagus: A prospective cohort study

Endoscopy

Volumn 40, Issue 9, 2008, Pages 711-716

  Martinek, Jan ^a   Benes, M ^a   Brandtl, P ^a   Hucl, T ^a   Vasicek, M ^a   Voska, L ^a   Lanska, V ^a   Nosek, V ^a   Spicak, J ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ANTIREFLUX OPERATION; ARTICLE; BARRETT ESOPHAGUS; BEDTIME DOSAGE; CANCER DIAGNOSIS; CANCER INCIDENCE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; FEMALE; HIATUS HERNIA; HIGH GRADE INTRAEPITHELIAL NEOPLASIA; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFLUX ESOPHAGITIS; REMISSION; STOMACH FUNDOPLICATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CARCINOMA IN SITU; COHORT STUDIES; COMORBIDITY; ENDOSCOPY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERNIA, HIATAL; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 51549095951     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1077502     Document Type: Article

References (28)

1. Westhoff B, Brotze S, Weston S et al. The frequency of Barrett's esophagus in high-risk patients with chronic GERD. Gastrointest Endosc 2005; 61: 226-231
2. Boyer J, Laugier R, Chemali M et al. French Society of Digestive Endoscopy SFED guideline: monitoring of patients with Barrett's esophagus. Endoscopy 2007; 39: 840-842
3. Ell C, May A, Gossner L et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000; 118: 670-677
4. Bartelsman JF, Hameeteman W, Tytgat GN. Barrett's esophagus. Eur J Cancer Prev 1992; 1: 323-325
5. Achkar E, Carey W. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Am J Gastroenterol 1988; 83: 291-294
6. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar lined (Barrett's) esophagus. N Engl J Med 1985; 313: 857-859
7. Csendes A, Braghetto I, Brudiles P et al. Long-term results of classic anti-reflux surgery in 152 patients with Barrett's esophagus: clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation. Surgery 1998; 126: 645-657
8. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997; 92: 212-215
9. Ferraris R, Bonelli L, Conio M et al. Incidence of Barrett's adenocarcinoma in an Italian population: an endoscopic surveillance programme. Eur J Gastroenterol Hepatol 1997; 9: 881-885
10. Hameeteman W, Tytgat GN, Houthoff HJ et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96: 1249-1256
11. Williamson WA, Ellis FHJ, Gibb SP et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991; 151: 2212-2216
12. Cooper BT, Chapman W, Neumann CS et al. Continuous treatment of Barrett's esophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Aliment Pharmacol Ther 2006; 23: 727-733
13. Conio M, Blanchi S, Lapertosa G et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol 2003; 98: 1931-1939
14. Sharma P, Falk GW, Weston AP et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006; 4: 566-572
15. Gladman L, Chapman W, Iqbal TH et al. Barrett's esophagus: an audit of surveillance over a 17-year period. Eur J Gastroenterol Hepatol 2006; 18: 271-276
16. Shaheen NJ, Crosby MA, Bozymski EM et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119: 333-338
17. El-Serag HB, Aguirre TV, Davis S et al. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol 2004; 99: 1877-1883
18. Hillman LC, Chiragakis L, Shadbolt B et al. Proton pump inhibitor therapy and the development of dysplasia in patients with Barrett's esophagus. Med J Austr 2004; 180: 387-391
19. Sharma P, McQuaid K, Dent J et al. A critical review of the diagnosis and the management of Barrett's esophagus: The AGA Chicago Workshop. Gastroenterology 2004; 127: 310-330
20. Valkil N, van Zanten SV, Kahrilas P et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-1920
21. Wang KK, Wongkeesong M, Buttar NS. AGA technical review on the role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology 2005; 128: 1471-1505
22. Provenzale D, Schmitt C, Wong JB. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999; 94: 2043-2053
23. Ell C, May A, Pech O et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 2007; 65: 3-10
24. Lim CH, Treanor D, Dixon ME, Axon ATR. Low-grade dysplasia in Barrett's esophagus has a high risk of progression. Endoscopy 2007; 39: 581-587
25. Rex DK, Cummings OW, Shaw M et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003; 125: 1670-1677
26. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461-467
27. Edelstein ZR, Farrow DC, Bronner MP et al. Central adiposity and risk of Barrett's esophagus. Gastroenterology 2007; 133: 403-411
28. Vicari JJ, Peek RM, Falk GW et al. The seroprevalence of Cag-A positive H. pylori strains in the spectrum of gastro-esophageal reflux disease. Gastroenterology 1998; 115: 50-57